Comp Set LASA MANGALAM× BIOFILCHEM× ORTINGLOBE× + VINEETLAB + KREBSBIO + ALPA + BALPHARMA + NATCAPSUQ + NECLIFE + AAREYDRUGS + MEDICAMEQ + MEDICO
In ₹ Crore except Per Share
Latest Annual
LASA
FY26
MANGALAM
FY26
BIOFILCHEM
FY26
ORTINGLOBE
FY26
Peer
Average
Valuation — at last close P/E — — 17.11× — 17.11× P/B 0.47× ◆ 0.45×2.21× 8.16× 3.61× -87% EV/EBITDA -1.14× -10.12× 72.85× ◆ -10.14×17.53× -107% Market Cap ₹23.4 Cr ₹46.1 Cr ₹47.6 Cr ₹10.1 Cr ₹34.6 Cr -32% Growth Revenue CAGR 3Y -42.11% — ◆ -1.85%-74.44% -38.14% -10% Revenue CAGR 5Y -34.11% — ◆ -4.50%-58.50% -31.50% -8% Net Income CAGR 3Y — — 70.67% — 70.67% Revenue YoY (latest Q) -93.87% -0.40% ◆ 91.99%-70.85% 6.91% -1458% Net Income YoY (latest Q) ◆ 83.05%44.64% -95.47% -92.65% -47.83% +274% Profitability EBITDA Margin -112.98% -6.42% ◆ 2.29%-1030.05% -344.73% +67% Net Income Margin -135.60% -19.13% ◆ 9.81%-736.72% -248.68% +45% Return on Common Equity -51.13% -35.23% ◆ 13.81%-46.06% -22.49% -127% Return on Capital Employed -51.42% -22.60% ◆ 1.83%-46.34% -22.37% -130% Return on Assets -40.63% -13.03% ◆ 5.94%-17.57% -8.22% -394% Credit & Quality Total Debt/Equity 0.20× 1.02× ◆ 0.14×0.81× 0.66× -70% Interest Coverage -89.13× -2.04× ◆ 37.37×-470.77× -145.15× +39% Scale — latest FY Revenue / Total Income ₹25.1 Cr ₹232 Cr ₹28.4 Cr ₹0.1 Cr ₹86.9 Cr -71% Net Income −₹34.1 Cr −₹44.4 Cr ₹2.8 Cr −₹0.7 Cr −₹14.1 Cr -141% Total Assets ₹66.3 Cr ₹315 Cr ₹42.8 Cr ₹4.6 Cr ₹121 Cr -45% EPS ₹-6.8 ₹-28.05 ₹1.71 ₹-0.91 ₹-9.08 +25% Book Value per Share ₹9.9 ₹65.11 ₹13.25 ₹1.52 ₹26.63 -63%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › » Latest: FY26 · Standalone CHART » ALPHA AI » COMP » FA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95% .
